Jian Irish
Presidente presso METAGENOMI, INC.
Patrimonio netto: 4 M $ in data 30/04/2024
Posizioni attive di Jian Irish
Società | Posizione | Inizio | Fine |
---|---|---|---|
METAGENOMI, INC. | Direttore/Membro del Consiglio | - | - |
Direttore operativo | 01/01/2021 | - | |
Presidente | 01/11/2021 | - |
Storia della carriera di Jian Irish
Precedenti posizioni note di Jian Irish
Società | Posizione | Inizio | Fine |
---|---|---|---|
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Direttore operativo | 01/01/2021 | 01/01/2022 |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Direttore/Membro del Consiglio | 01/10/2018 | 01/04/2020 |
Direttore Tecnico/Scientifico/R&S | 01/10/2018 | 01/04/2020 | |
SANOFI | Corporate Officer/Principal | 01/01/2014 | 01/01/2016 |
AMGEN INC. | Corporate Officer/Principal | - | - |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Direttore operativo | 01/01/2021 | - |
Presidente | 01/11/2021 | - | |
KITE PHARMA INC | Corporate Officer/Principal | - | - |
Formazione di Jian Irish
Chiba University | Doctorate Degree |
East China University of Science & Technology | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Cina | 3 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Operating Officer | 3 |
Director/Board Member | 2 |
Settori
Health Technology | 8 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
AMGEN INC. | Health Technology |
SANOFI | Health Technology |
METAGENOMI, INC. | Health Technology |
Aziende private | 4 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Jian Irish
- Esperienza